hydroquinone has been researched along with Vitiligo in 17 studies
Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Galangin, the main active component of Alpinia officinarum Hance, was tested in a mouse model of vitiligo induced in C57BL/6 mice by the topical application of 2 mL of 2." | 7.80 | The effects of galangin on a mouse model of vitiligo induced by hydroquinone. ( Gao, L; Ge, CH; Huo, SX; Liu, XM; Peng, XM; Yan, M; Zhao, PP, 2014) |
| "Chemical leukoderma is an acquired type of vitiligo that can be initiated by various exogenous chemicals such as hydroquinone (HQ), rhododendrol (RD), or 4-tertiary butyl phenol (4-TBP)." | 3.91 | Keratinocyte-derived IL-36γ plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. ( Ahn, S; An, S; Choi, D; Choi, H; Choi, J; Jin, SH; Kim, HJ; Lee, E; Noh, M; Pyo, JJ; Shin, JC, 2019) |
| "Galangin, the main active component of Alpinia officinarum Hance, was tested in a mouse model of vitiligo induced in C57BL/6 mice by the topical application of 2 mL of 2." | 3.80 | The effects of galangin on a mouse model of vitiligo induced by hydroquinone. ( Gao, L; Ge, CH; Huo, SX; Liu, XM; Peng, XM; Yan, M; Zhao, PP, 2014) |
| " It is assumed that acrylates induced contact vitiligo, but the dental acrylics may have also contained other chemicals (eg, hydroquinone or phenolic substances) capable of causing vitiligo." | 3.70 | Contact leukoderma caused by patch testing with dental acrylics. ( Estlander, T; Kanerva, L, 1998) |
| "Traditionally, the treatment of vitiligo has focused on pharmacologic interventions, but nearly half of all treated patients fail to respond successfully." | 2.48 | Advanced treatment modalities for vitiligo. ( Cohen, GF; Paghdal, KV; Patel, NS, 2012) |
| "Vitiligo is a relatively common acquired skin depigmentary disease with a complex presentation, therapy, and etiology." | 2.47 | Vitiligo: current medical and scientific understanding. ( Boissy, RE; Nordlund, JJ, 2011) |
| "The two autoimmune diseases are not only linked by a concordance of clinical presentations and an autoimmune/oxidative stress-mediated toxicity pathogenesis but also by an apparent biochemical commonality." | 1.51 | Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis. ( Bellanti, JA; Calderone, R; Li, D; Liang, G, 2019) |
| "Vitiligo is characterized by depigmentation in large or small areas of the skin." | 1.27 | Vitiligo. ( Dunn, JF, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, JE | 1 |
| Huo, SX | 2 |
| Wang, Q | 1 |
| Liu, XM | 2 |
| Ge, CH | 2 |
| Gao, L | 2 |
| Peng, XM | 2 |
| Yan, M | 2 |
| Kim, H | 1 |
| Park, CS | 1 |
| Lee, AY | 1 |
| Zubair, R | 1 |
| Lyons, AB | 1 |
| Vellaichamy, G | 1 |
| Peacock, A | 1 |
| Hamzavi, I | 1 |
| Li, D | 1 |
| Liang, G | 1 |
| Calderone, R | 1 |
| Bellanti, JA | 1 |
| Pyo, JJ | 1 |
| Ahn, S | 1 |
| Jin, SH | 1 |
| An, S | 1 |
| Lee, E | 1 |
| Choi, J | 1 |
| Shin, JC | 1 |
| Choi, H | 1 |
| Kim, HJ | 1 |
| Choi, D | 1 |
| Noh, M | 1 |
| Zhao, PP | 1 |
| Boissy, RE | 1 |
| Nordlund, JJ | 1 |
| Patel, NS | 1 |
| Paghdal, KV | 1 |
| Cohen, GF | 1 |
| CANIZARES, O | 1 |
| URIBE JARAMILLO, F | 1 |
| KERDEL VEGAS, F | 1 |
| Fisher, AA | 2 |
| Kanerva, L | 1 |
| Estlander, T | 1 |
| Lerner, MR | 1 |
| Fitzpatrick, TB | 1 |
| Halder, RM | 1 |
| Hawk, JL | 1 |
| Kim, YJ | 1 |
| Chung, BS | 1 |
| Choi, KC | 1 |
| Das, M | 1 |
| Tandon, A | 1 |
| Dunn, JF | 1 |
4 reviews available for hydroquinone and Vitiligo
| Article | Year |
|---|---|
Chemical-Induced Vitiligo.
Topics: Autoimmunity; Catechols; Hair Dyes; Humans; Hydroquinones; Hypopigmentation; Phenols; Phenylenediami | 2017 |
What's New in Pigmentary Disorders.
Topics: alpha-MSH; Antifibrinolytic Agents; Bimatoprost; Dermatologic Agents; Humans; Hydroquinones; Inflamm | 2019 |
Vitiligo: current medical and scientific understanding.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Genetic Association Studies; Genetic Predisposition to | 2011 |
Advanced treatment modalities for vitiligo.
Topics: Dermabrasion; Humans; Hydroquinones; Khellin; Lasers, Excimer; Low-Level Light Therapy; Melanocytes; | 2012 |
13 other studies available for hydroquinone and Vitiligo
| Article | Year |
|---|---|
The Effect of Butin on the Vitiligo Mouse Model Induced by Hydroquinone.
Topics: Animals; Benzopyrans; Cell Survival; Epidermis; Hair Follicle; Humans; Hydroquinones; Male; Malondia | 2017 |
Reduced Nrf2 activation in PI3K phosphorylation-impaired vitiliginous keratinocytes increases susceptibility to ROS-generating chemical-induced apoptosis.
Topics: Adolescent; Adult; Antioxidants; Apoptosis; Cell Survival; Cells, Cultured; Epidermis; Female; Gene | 2017 |
Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis.
Topics: Animals; Autoimmune Diseases; Autoimmunity; Benzoquinones; Disease Models, Animal; Hashimoto Disease | 2019 |
Keratinocyte-derived IL-36γ plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes.
Topics: Cytokines; Humans; Hydroquinones; Hypopigmentation; Interleukin-1; Interleukin-17; Keratinocytes; Me | 2019 |
The effects of galangin on a mouse model of vitiligo induced by hydroquinone.
Topics: Alpinia; Animals; Flavonoids; Hydroquinones; Male; Malondialdehyde; Melanins; Melanocytes; Methoxsal | 2014 |
Leukomelanoderma subsequent to the application of monobenzyl ether of hydroquinone; a vitiligoid reaction observed in Colombia and Venezuela.
Topics: Colombia; Ether; Ethers; Hydroquinones; Phenols; Venezuela; Vitiligo | 1958 |
Differential diagnosis of idiopathic vitiligo from contact leukoderma. Part II: Leukoderma due to cosmetics and bleaching creams.
Topics: Adult; Butylated Hydroxytoluene; Catechols; Cosmetics; Dermatitis, Contact; Diagnosis, Differential; | 1994 |
Differential diagnosis of idiopathic vitiligo. Part III: Occupational leukoderma.
Topics: Anti-Infective Agents, Local; Dermatitis, Occupational; Diagnosis, Differential; Humans; Hydroquinon | 1994 |
Contact leukoderma caused by patch testing with dental acrylics.
Topics: Acrylic Resins; Dental Materials; Dermatitis, Allergic Contact; Dermatitis, Occupational; Female; Ha | 1998 |
Discussion of a case of vitiligo.
Topics: Adrenal Cortex Hormones; Child; Humans; Hydroquinones; Male; PUVA Therapy; Vitiligo | 1999 |
Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis.
Topics: Aged; Female; Humans; Hydroquinones; Laser Coagulation; Melanocytes; PUVA Therapy; Vitiligo | 2001 |
Occupational vitiligo.
Topics: Adult; Dermatitis, Occupational; Humans; Hydroquinones; Male; Vitiligo | 1988 |
Vitiligo.
Topics: Adolescent; Adult; Autoimmune Diseases; Child; Child, Preschool; Diagnosis, Differential; Female; Fl | 1986 |